Odyssean »

Noble Corp shares owned by Odyssean

Quarter-by-quarter ownership of Noble Corp (NE) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Noble Corp

Tip: Access up to 7 years of quarterly data

All positions including Noble Corp held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Noble Corp by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $226k 6.1k 37.30

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Noble Corp

BlackRock
First Eagle Investment Management
Vanguard Portfolio Management
Dimensional Fund Advisors
Vanguard Capital Management
FMR
State Street Corporation
American Century Companies
Sourcerock Group
Geode Capital Management
Capital World Investors
Neuberger Berman Group
Van Eck Associates Corp.
Charles Schwab Investment Management
Morgan Stanley

View all funds holding Noble Corp